Stryker's income up 20% on 6% sales increase:
This article was originally published in Clinica
Stryker's first-quarter sales increased 6% to $254 million, while net income rose 20% to $36 million. Kalamazoo, Michigan-based Stryker's domestic sales were up 14% to $171 million and were boosted by strong shipments of endoscopic equipment, powered surgical instruments and orthopaedics implants. International sales, hit by lower business to the Asian market and the exchange rate effects, fell 8% to $82 million.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.